View:
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934
JUNE 12, 1998
-------------
(Date of earliest event reported)
LABORATORY CORPORATION OF AMERICA HOLDINGS
------------------------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 1-11353 13-3757370
-------- ------- ----------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification
incorporation) Number)
358 SOUTH MAIN STREET, BURLINGTON, NORTH CAROLINA 27215
-------------------------------------------------------
(Address of principal executive offices)
336-229-1127
------------
(Registrant's telephone number, including area code)
ITEM 5. OTHER EVENTS
On June 12, 1998, the Company issued a press release
announcing that its Board of Directors has declared
dividends on the Company's 8 1/2% Series A Convertible
Exchangeable Preferred Stock and the Company's 8 1/2% Series
B Convertible Pay-in-Kind Preferred Stock.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL
INFORMATION AND EXHIBITS
(c) Exhibit
20 Press release of the Company dated June 12, 1998.
SIGNATURES
Pursuant to the requirements of the Securities and
Exchange Act of 1934, the registrant has duly caused this
report to be signed on its behalf by the undersigned
hereunto duly authorized.
LABORATORY CORPORATION OF AMERICA HOLDINGS
------------------------------------------
(Registrant)
By:/s/ BRADFORD T. SMITH
------------------------------
Bradford T. Smith
Executive Vice President,
General Counsel, Secretary
and Compliance Officer
Date: July 7, 1998
FOR IMMEDIATE RELEASE CONTACT: PAMELA SHERRY
- --------------------- 336-584-5171, EXT. 4855
SHAREHOLDER DIRECT: 800-LAB-0401
WWW.LABCORP.COM
LABORATORY CORPORATION OF AMERICA-REGISTERED TRADEMARK-DECLARES
PREFERRED STOCK DIVIDENDS
BURLINGTON, NC, JUNE 12, 1998 - Laboratory Corporation of America-Registered
Trademark-Holdings (LabCorp-Registered Trademark-) (NYSE: LH) today announced
that its Board of Directors has declared a dividend of $1.0625 per share on
the Company's 8 1/2 % Series A Convertible Exchangeable Preferred Stock
(Series A Preferred Stock), payable in cash. The Board has also declared a
dividend of $1.0625 per share on the Company's 8 1/2 % Series B Convertible
Pay-in-Kind Preferred Stock (Series B Preferred Stock), payable in shares of
Series B Preferred Stock at the rate of 0.02125 shares per share of Series B
Preferred Stock held. No fractional shares of Series B Preferred Stock will
be issued, so that the number of shares to be paid as a dividend on the Series
B Preferred Stock will be rounded to the nearest whole number of shares. The
dividends will be payable on June 30, 1998 for each issued and outstanding
share of Series A and B Preferred Stock to stockholders of record on June 24,
1998, and will cover the dividend period from April 1, 1998 to June 30, 1998
at an equivalent annualized rate of $4.25 per share.
Laboratory Corporation of America-Registered Trademark-Holdings (LabCorp-
Registered Trademark-) is a national clinical laboratory organization with
annual revenues of $1.5 billion in 1997. The Company operates primary testing
facilities nationally, offering more than 1,700 different clinical assays,
from routine blood analyses to more sophisticated technologies. LabCorp
performs diagnostic tests for physicians, managed-care organizations,
hospitals, clinics, long-term care facilities, industrial companies and other
clinical laboratories.